← brief for 2026-10-11 · Slowing decline

SGLT2 beyond the kidney: an inducible player in endothelial dysfunction and cardiovascular diseases

Article No results yet Peer reviewed

Key takeaways

This review discusses how SGLT2 drugs, which are often used for diabetes, affect the heart and blood vessels. It notes that these drugs help with heart failure and kidney disease. The article summarizes existing evidence but does not report new trial results.

Who did this work

Antonin Trimaille (Hôpitaux Universitaires de Strasbourg) · Sophie Kerth (Deutsches Herzzentrum München) · Ali Mroueh (Université de Strasbourg) · Walaa Kamel Fakih (Université de Strasbourg) · Sandy Hmadeh (Université de Strasbourg) · Hira Muzammel (Université de Strasbourg) · Laurence Jesel (Hôpitaux Universitaires de Strasbourg) · Agnes Görlach (Deutsches Herzzentrum München) · Olivier Morel (Hanoi Medical University) · Valérie B. Schini‐Kerth (Université de Strasbourg)

Source

Article · OpenAlex, CKD works · 2026-10-10
https://doi.org/10.1186/s12933-026-03394-8